1994
DOI: 10.1007/bf02229876
|View full text |Cite
|
Sign up to set email alerts
|

Lack of response to corticosteroids and pulse cyclophosphamide therapy in Cogan's syndrome

Abstract: A 17-year-old girl with Cogan's syndrome is described. Total and irreversible hearing loss occurred which was unresponsive to corticosteroids and immunosuppressive therapy. The girl died a year later from subarachnoid haemorrhage. The lethal prognosis in Cogan's syndrome despite the available treatment is emphasized.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
13
0

Year Published

2001
2001
2019
2019

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 20 publications
(14 citation statements)
references
References 11 publications
1
13
0
Order By: Relevance
“…One of the pediatric patients had arthritis, [6,7] but arthralgia and myalgia had been reported in children and were also present in our case [5,8]. Fever, headache, maculopapular rash, abdominal pain, nausea, vomiting, and lymphadenopathy may be seen in children with CS [2,6,7,8].…”
Section: Discussionsupporting
confidence: 52%
See 3 more Smart Citations
“…One of the pediatric patients had arthritis, [6,7] but arthralgia and myalgia had been reported in children and were also present in our case [5,8]. Fever, headache, maculopapular rash, abdominal pain, nausea, vomiting, and lymphadenopathy may be seen in children with CS [2,6,7,8].…”
Section: Discussionsupporting
confidence: 52%
“…Vestibuloauditory dysfunction usually starts suddenly with Meniere's-like attacks, but only four patients in the pediatric sector reported cases presenting with acute attacks [6,7]. However, sensorineural deafness of variable severity, whether transient or permanent, was found in all of the pediatric cases, including ours.…”
Section: Discussionmentioning
confidence: 73%
See 2 more Smart Citations
“…12,45,46 However, these drugs have adverse effects, which limit their prescription in children, and their efficacy is controversial in Cogan's syndrome. For these reasons these agents should never be prescribed as a first treatment in children.…”
Section: Treatment and Prognosismentioning
confidence: 99%